References
- Aviram, M. 1996. Interaction of oxidised low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Eur. J. Clin. Chem. Clin. Biochem. 34, 599-607.
- Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A, Watson, A. D. and Lusis, A. J. 1995. Atherosclerosis: basic mechanisms. oxidation, inflammation, and genetics. Circulation 91, 2488-2496. https://doi.org/10.1161/01.CIR.91.9.2488
- Chiu, Y. T., Howard, E. W., Lee, D. T., Chua, C. W., Wang, X. and Wong, Y. C. 2008. Evidence of a novel docetaxel sensitizer, garlicderived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer. Int. J. Cancer 122, 1941-1948. https://doi.org/10.1002/ijc.23355
- Esterbauer, H., Striegl, G., Puhl, H. and Rotheneder, M. 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6, 67-75. https://doi.org/10.3109/10715768909073429
- Evans, P. J., Smith, C., Mitchinson, M. J. and Halliwell, B. 1995. Meta lion release from mechanically disrupted human arterial wall. Implications for the development of atherosclerosis. Free Redic. Res. 25, 465-469.
- Fuster, V. 1994. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology (Lewis, A. Conner Meorial Lecture). Circulation 90, 2126-2134. https://doi.org/10.1161/01.CIR.90.4.2126
- Gey, K. F. 1995. Ten-year retrospective on the antioxidant hypothesis of atherosclerosis: Threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J. Nutr. Biochem. 6, 206-212. https://doi.org/10.1016/0955-2863(95)00032-U
- Greenspan, P. and Gutman, R. L. 1993. Detection by nile red of agarose fel electrophoresed native and modified low density lipoprotein. Electrophoresis 14, 65-68. https://doi.org/10.1002/elps.1150140111
- Havel, R. J., Eder, H. A. and Bragdon, J. H. 1995. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1352.
- Howard, E. W., Ling, M. T., Chua, C. W., Cheung, H. W, Wang, X. and Wong, Y. C. 2007. Garlic-derived S-allylmer-captocysteine is a novel in vivo antimetastatic agent for and rogenindependent prostate cancer. Clin. Cancer Res. 13, 1847-1856. https://doi.org/10.1158/1078-0432.CCR-06-2074
- Ide, N. and Lau, B. H. 1997. Garlic compounds protect vascular endothelial cells from oxidized low density lip-oprotein-induced injury. J. Pharm. Pharmacol. 49, 908-911. https://doi.org/10.1111/j.2042-7158.1997.tb06134.x
-
Ide, N., Nelson, A. B. and Lau, B. H. 1997. Aged garlic extract and its constituents inhibit
$Cu^{2+}$ -induced oxidative modification of low density lipoprotein. Planta Med. 63, 263-264. https://doi.org/10.1055/s-2006-957668 - Kuzuya, M. and Kuzuya, F. 1993. Probucol as an antioxidant and antiatherogenic drug. Free Rad. Biol. Med. 14, 67-77. https://doi.org/10.1016/0891-5849(93)90510-2
- Lawson, L. D. 1996. The composition and chemistry of garlic cloves and processed garlic, in garlic: The science and therapeutic application of allium sativum L. and related species. 2nd eds. In Koch, H. P. and Lawson, L. D. (eds.), pp. 37-107, Williams and Wilkins, Baltimore.
- Lawson, L. D. 1998. Garlic: review of its medicinal effects and indicated active compounds. In Phytomedicines of Europe, Chemistry and Biological Activity Edited by: Lawson, L. D., Bauer, R. Washington DC: ACS Symposium series 691. American Chemical Society pp. 176-209.
- Lowry, O. H., Rosebrough, N. J., Far, A. L. and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
- Maldonado, P. D., Barrera, D., Medina-Campos, O., Hernandez-Pando, R., Ibarra-Rubio, M. E. and Pedraza-Chaverri, J. 2003. Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats. Life Sci. 73, 2543-2556. https://doi.org/10.1016/S0024-3205(03)00609-X
- Munday, J. S., James, K. A., Fray, L. M., Kirkwood, S. W. and Thompson, K. G. 1999. Daily supplementation with aged extract, but not raw garlic, protect low density lipoprotein against in vitro oxidation. Atherosclerosis 143, 399-304. https://doi.org/10.1016/S0021-9150(98)00293-7
- Navab, M., Fogelman, A. M., Berliner, J. A., Territo, M. C., Demer, L. L., Frank, J. S., Watson, A. D., Edwards, P. A. and Lusis, A. J. 1995. Pathogenesis of atherosclerosis. Am. J. Cardiol. 76, 18C https://doi.org/10.1016/S0002-9149(99)80466-4
- Parthasarathy, S., Steinberg, S. D. and Witztum, J. L. 1992. The role of oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann. Rev. Med. 43, 219-227. https://doi.org/10.1146/annurev.me.43.020192.001251
- Phelps, S. and Harris, W. S. 1993. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 28, 475-484. https://doi.org/10.1007/BF02535949
- Pietta, P. and Simonetti, P. 1996. Dietary flavonoids and interaction with endogenous antioxidants, Biochem. Mol. Biol. Inter. 44, 1069-1074.
- Pinto, J. Y., Lapsia, S., Shah, A., Santiago, H. and Kim, G. 2000. Antiprofierative effect of garlic derived and other allium related compounds, In Nutrition and Cancer Prevention : New insights into the role of phytochemicals : Advances in experimental medicine and biology. American institute for cancer research (eds). Vol. 492.
- Puhl, H., Waeg, G. and Esterbauer, H. 1994. Methods to determine oxidation of low density lipoprotein. Method Enzymol. 233, 425-432. https://doi.org/10.1016/S0076-6879(94)33049-2
- Smith, C., Michinson, M. J., Aruoma, I. O. and Halliwell, B. 1992. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286, 901-905.
- Srivastava, K. C., Bordia, A. and Verma, S. K. 1995, Garlic (Allium sativum) for disease prevention, South African J. Sci. 91, 68-77.
- Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. and Wiztum, J. L. 1987. Modifications of low density lipoprotein that increases its atherogenicity. N. Engl. J. Med. 320, 915-924.
- Steinbrecher, U. P., Zhang, H. and Lougheed, M. 1990. Role of oxidatively modified LDL in atherosclerosis. Free Rad. Biol. Med. 9, 155-168.
- Sumioks, I., Matsura, T. and Yamade, K. 2001. Therapeutic effect of S-allylmercaptocysteine on acetaminophen-induced liver injury in mice. Eur. J. Pharmacol. 433, 177-185. https://doi.org/10.1016/S0014-2999(01)01503-5
- Sumioks, I., Matsura, T., Kasuga, S., Itakura, Y. and Yamada, L. 1998. Mechanisms of protection by S-allylmercaptocys-teine against acetaminophen-induced liver injury in mice. Jpn. J. Pharmacol. 78, 199-207. https://doi.org/10.1254/jjp.78.199
- Swain, J. and Gutteridge, T. M. 1995. Proxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material FEBS. Letters 368, 513-515. https://doi.org/10.1016/0014-5793(95)00726-P
- Xiao, D., Pinto, J. T., Soh, J. W., Deguchi, A., Gundersen, G. G., Palazzo, A. F., Yoon, J. T., Shirin, H. and Weinstein, I. B. 2003. Induction of apoptosis by the garlicderived compound S-allylmercaptocysteine (SAMC) is associated with microtuble depolymerization and cJun NH(2)-terminal kinase 1 activation. Cancer Res. 63, 25-37.
- Yaki, K. 1976. A simple fluorometric assay for lipoprotein in blood plasma. Biochem. Med. 15, 212-217. https://doi.org/10.1016/0006-2944(76)90049-1